Market Overview

Zogenix Shares Rally as FDA Redschedules Hydrocodone Drugs Panel

Related ZGNX
Morning Market Movers
Zogenix Provides Update On Development Of Abuse Deterrent Formulations Of Zohydro ER

Shares of Zogenix (NASDAQ: ZGNX) rallied more than 10 percent on Tuesday following news the FDA rescheduled an advisory panel for hydrocodone drugs to January 24th-25th.

View pdf.

Posted-In: News FDA Movers

 

Most Popular

Related Articles (ZGNX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free